Assertio Holdings | DEPO - Betriebsaufwand





Betriebsaufwand Veränderung Datum
ANI Pharmaceuticals USD 562.3M 344.37M 2026-03
Assertio Holdings USD 105.8M 12.5M 2025-09
Aurora Cannabis CAD 129.98M 16.05M 2025-12
Cara Therapeutics USD 5.94M 983K 2025-09
Daiichi Sankyo JPY 468.57B 15.34B 2025-12
Ironwood Pharmaceuticals USD 57.33M 8.63M 2024-12
J&J USD 17.44B 1.53B 2026-03
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Merck USD 18.17B 8.01B 2026-03
Nektar Therapeutics USD 40.9M 44.19M 2025-12
Omeros USD 59.16M 20.13M 2024-06
Pfizer USD 90.1B 77.19B 2026-03
Teva Pharmaceutical Industries USD 3.22B 1000M 2026-03